Thursday, June 30, 2022

These 4 countries accept Indian Pharmacopoeia (IP) as book of standard
In a bid to increase its efforts towards recognition and acceptance of IP in foreign countries, the Indian Pharmacopoeia Commission (IPC) has submitted proposals to various countries through the Ministry of Health and Family Welfare, Ministry of Commerce and Industry, and Ministry of External Affairs, according to a statement by IPC.

The statement said that it is a matter of delight to share that pursuant to sincere efforts and guidance provided by the Union Minister of Health and Family Welfare to get IP recognised in foreign countries, IP has been accepted as a book of standards in a total of four countries, with details as appended below:

Click for more articles on IPC - Indian Pharmacopoeia Commisssion

Afghanistan: IP has been recognised formally by the National Department of Regulation of Medicines and Health Products of the Ministry of Public Health of the Islamic Republic of Afghanistan and will also be used based on the requirements of reputable pharmacopoeia in the laboratory of medicines and health products quality. A new beginning has been made as Afghanistan has become the first country to recognise the IP.

Ghana: IP is considered an approved reference when its monograph compares with the monographs in recognised pharmacopoeias in the Fourth Schedule of the Public Health Act.

 Nepal: IP is recognised as the book of standards in Drugs Category Rules 1986 of Nepal. As per the list of pharmacopoeia or encyclopedia related to the category of drugs under Schedule 1 (related to Rule 5) of the Drugs Category Rules 1986, “Pharmacopoeia of India” published by the Ministry of Health of the Government of India has been included in Sr. No. 3.

Mauritius: In order to include IP in the standards of pharmaceuticals authorised in Mauritius, Section 2 of the Pharmacy Act 1983 has been amended through Section 50 of the legal supplement published in August 2020 and in the definition of “specified standards” of Section 2 of the Pharmacy Act, the word “or European” has been deleted and replaced with the words “European or Indian.”

Accordingly, the amended section reads as “specified standards," which means such standards are specified in the British, French, US, European, or Indian Pharmacopoeia, the statement added.

Efforts are on to add more countries to the list and stakeholders are encouraged to take advantage of this recognition, the statement stated.

In addition to it, with a view to further strengthening the standards of drugs in India, IPC is releasing a new, 9th edition of IP (IP 2022) on July 1st, 2022.

Mansukh Mandaviya, Minister of Health and Family Welfare, will be releasing the new edition. The event will be hosted at Vigyan Bhawan, Maulana Azad Road, as per another statement by IPC.

The statement said that the publication of the 9th edition of IP will make a big contribution to improving and ensuring the quality of medicines and the overall strengthening of the regulation of the drug in India, said the statement.

To mark the occasion of the publication and release of the IP 2022 on 1st July, IPC is also organising a one-day scientific conference on the theme of ‘Addressing Medicine Quality for Future.’

Since the main users of IP are from the pharma industry, the target audience for the conference will be leading pharma companies, pharma MSMEs, regulatory authorities, industry bodies like IDMA, BDMA, IPA, etc, and academia, the statement concluded.

Must read

Latest Circulars: (IPC) Indian Pharmacopoeia Commission

Latest Notifications regarding Pharmaceuticals

Latest on National Formulary of India (NFI)

DCGI approves India’s first mRNA vaccine against C-19

Govt in talks with UAE to recognise Indian Pharmacopoeia

Medical device alert: CDSCO issues alert on batches of peripheral stent from US-based Cordis

3D printing: Future for Pharma Industry for easy fabrication of Tablets with multiple APIs

USFDA declines to approve this Urinary Tract Infection Drug

FDA warning against self-medication

IPA calls Nutraceutical, Pharma industries to join hands to provide holistic care

PCI planning to help pharmacists fight e-Pharmacies

Drug Alert: NSQ Drugs Lists

Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/06/30/these-4-countries-accept-indian-pharmacopoeia-ip-as-book-of-standard/

No comments:

Post a Comment